State
73,806 recalls have nationwide distribution and so reach New York. 12,956 additional recalls listed New York specifically in their distribution scope.
Of the 12,956 recalls naming New York we have scored against our rubric, 1,508 (12%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 3,702 (29%) are Severe.
Which agencies issued them
These figures cover only the 12,956 recalls whose distribution notice names New York specifically. The 73,806 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.
Anderson Compounding Pharmacy is recalling HCG 11,000 mcg Injection vials nationwide due to a lack of sterility assurance.
MSM Nutraceuticals is recalling Red Eye Eye Drops because the product lacks assurance of sterility and was not tested per USP 71.
Anderson Compounding Pharmacy is recalling Lidocaine 1%/Dextrose 12.5% Injection vials due to a lack of sterility assurance.
Anderson Compounding Pharmacy is recalling Gentamicin irrigation syringes due to a lack of sterility assurance. The recall covers all lots distributed nationwide.
Anderson Compounding Pharmacy is recalling Phenylephrine 1 mg/mL Injection vials nationwide because the product lacks sterility assurance.
Anderson Compounding Pharmacy is recalling 22 vials of Sermorelin 0.3 mg/0.5 mL nationwide due to a lack of sterility assurance.
Anderson Compounding Pharmacy is recalling Prostaglandin Tri-Mix Injection due to lack of sterility assurance. The recall covers all lots distributed nationwide.
ICU Medical is recalling specific lots of ChemoClave Vial Spikes because they may contain plastic burr particulate from the protective cap used during assembly.
Anderson Compounding Pharmacy is recalling Heparin and Lidocaine syringes due to a lack of sterility assurance. The recall covers all lots distributed nationwide.
Anderson Compounding Pharmacy is recalling Prostaglandin Tri-Mix 60:30:1 Injection due to a lack of sterility assurance. The recall covers all lots distributed nationwide.
ICU Medical is recalling specific lots of ChemoLock Vial Spikes because they may contain plastic burr particulate from the protective cap.
Anderson Compounding Pharmacy is recalling 99 vials of HCG 20 Day Extra Strength nationwide due to a lack of sterility assurance.
Anderson Compounding Pharmacy is recalling Methylcobalamin 1 mg/mL Injection vials due to a lack of sterility assurance.
Anderson Compounding Pharmacy is recalling Vitamin D3 200,000 IU/mL Injection vials nationwide due to a lack of sterility assurance.
ICU Medical is recalling certain lots of ChemoClave Vented Vial Spikes because plastic burrs from the protective cap may contaminate the device.
ProSun International is recalling 31 Onyx 32 Sli Intensive tanning beds due to quality control documentation discrepancies that could result in high UV output.
BioFire Diagnostics is recalling FilmArray BCID Panels used with specific BACT/ALERT blood culture bottles due to an increased risk of false positive results for Enterobacteriaceae and E. coli.
Abbott is recalling 559 Alinity c Processing Modules because a safety interlock may fail to deploy when a bulk solution bottle is removed.
Gyrus ACMI is recalling Diego Elite Turbinate Blades because they may allow unintended RF energy activation when used with Olympus consoles.
Boston Salads & Provisions Co., Inc. is recalling 915 pounds of Edamame Salad due to possible metal fragment contamination. The product was distributed in MA, CT, RI, NH, and NY.
Gyrus ACMI is recalling 161 Diego Elite Malleable 4mm Standard Monopolar Blades because they may allow unintended RF energy activation when used with Diego Elite consoles.
GE Healthcare is recalling one Innova IGS 630 angiographic X-ray system because a specific user action may cause a loss of imaging function.
Medrobotics is recalling 24 Flex Robotic System obturators because a weld may break, causing the rod to separate from the cone.
Teva Pharmaceuticals is recalling specific lots of Amoxicillin Oral Suspension because assay results were below specification limits. The affected bottles were distributed nationwide and in Puerto Rico.
Roche Diagnostics is recalling Bilirubin Total Gen.3 assays due to new endogenous interference claims that may pose a potential medical risk.